SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-014651
Filing Date
2024-04-15
Accepted
2024-04-15 17:03:31
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 1476615
2 ex31-1.htm EX-31.1 17853
3 ex31-2.htm EX-31.2 17883
4 ex32-1.htm EX-32.1 7333
5 ex32-2.htm EX-32.2 7406
  Complete submission text file 0001493152-24-014651.txt   7471883

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE orgs-20230930.xsd EX-101.SCH 52743
7 XBRL CALCULATION FILE orgs-20230930_cal.xml EX-101.CAL 74517
8 XBRL DEFINITION FILE orgs-20230930_def.xml EX-101.DEF 251000
9 XBRL LABEL FILE orgs-20230930_lab.xml EX-101.LAB 402483
10 XBRL PRESENTATION FILE orgs-20230930_pre.xml EX-101.PRE 329926
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 1317383
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38416 | Film No.: 24845353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)